Skip to main content

Table 2 Accompanying diagnosis and medication at baseline

From: Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

Parameter

n

%*

Diabetes mellitus

1921

58.9

Hepatic steatosis

1258

38.6

Coronary artery disease

773

23.7

Benign prostatic hyperplasia

365

11.2

Nephropathy

315

9.7

Cardiac failure

306

9.4

Myocardial infarction

272

8.3

Cerebrovascular event

176

5.4

Active smoker

680

20.9

Former smoker

1012

31.1

Statins

1471

45.1

Orale antidiabetic drugs

1298

39.8

Betablockers

1088

33.4

Platelet Inhibitors

957

29.4

Calciumantagonists

735

22.6

Diuretics

637

19.5

Insulin

420

12.9

ACE-Inhibitors

337

10.3

Fibrates

200

6.1

  1. Medications reported in less than 3% are not indicated in the table; * sum >100% because some patients were taking more than 1 medication.